Literature DB >> 32253109

Prevalence and characteristics of gastric remnant cancer: A systematic review and meta-analysis.

Tsz Kin Mak1, Bingsheng Guan2, Juzheng Peng3, Tsz Hong Chong4, Cunchuan Wang5, Shifang Huang6, Jingge Yang7.   

Abstract

The incidence and outcomes of GRC remain variable. Minority published researches have paid attention to the characteristics of GRC. This study aimed to make a systematic review and meta-analysis of the prevalence of GRC, with a focus on characteristics and survival rates of GRC. PubMed, EMBASE, and CENTRAL were searched for related clinical studies. Data were pooled using Stata 11.0, and subgroup and sensitivity analyses were performed if necessary and feasible. Moreover, SPSS (version 19.0) was used for comparing the clinical characteristics of GRC. Twenty studies were selected in this meta-analysis. The results indicated that the pooled prevalence of GRC was 2.6% (95% confidence interval (CI), 2.2-3.0%, p = 0.000). European population and American populations have a higher rate of prevalence of GRC than Chinese populations and Japan. There is no significant difference in histology and the TNM stage between the benign group and the malignant group. The five-year survival rate for GRC cases with benign primary gastric diseases is poorer than the primary gastric diseases malignant. Gastric remnant cancer is not a very rare clinical problem, especially for European and American patients. Active treatment and regular follow-up are conductive to increase 5-years survival rate.
Copyright © 2020. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Gastric postgastrectomy cancer; Gastric remnant cancer; Gastric remnant carcinoma; Gastric stump cancer; Gastric stump carcinoma

Mesh:

Year:  2020        PMID: 32253109     DOI: 10.1016/j.asjsur.2020.03.012

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  4 in total

1.  SLC6A14 Depletion Contributes to Amino Acid Starvation to Suppress EMT-Induced Metastasis in Gastric Cancer by Perturbing the PI3K/AKT/mTORC1 Pathway.

Authors:  Qie Guo; Wen Xu; Xiao Li; Jia-Lin Sun; Xiao-Ce Gu; Fan-Bo Jing
Journal:  Biomed Res Int       Date:  2022-07-12       Impact factor: 3.246

2.  Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study.

Authors:  Li-Hua Li; Wen-Chao Chen; Gang Wu
Journal:  Dis Markers       Date:  2022-04-29       Impact factor: 3.434

3.  3D laparoscopic-assisted vs open gastrectomy for carcinoma in the remnant stomach: A retrospective cohort study.

Authors:  Di Wu; Qi-Ying Song; Xiong-Guang Li; Tian-Yu Xie; Yi-Xun Lu; Ben-Long Zhang; Shuo Li; Xin-Xin Wang
Journal:  World J Gastrointest Surg       Date:  2022-08-27

4.  Subtotal versus total gastrectomy for remnant gastric cancer: a systematic review and meta-analysis of observational studies.

Authors:  Ryota Otsuka; Koichi Hayano; Masahiro Yoshida; Hironobu Goto; Yusuke Muneoka; Souya Nunobe; Hisahiro Matsubara
Journal:  Langenbecks Arch Surg       Date:  2021-03-10       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.